Prevalence of non-adherence to antiretroviral therapy among people living with HIV and mitigation used to control in Kirinda District Hospital

Donatien Mbonyintwari, Emile Sebera, Leonisse Uwajeneza, Jerome Mfitumukiza, Larissa Mukire, Jean Damascene Dusabimana, Daniel Ukwishatse, Thierry Patrick Ishimwe, Denyse Umuhoza, Maurice Silari

Abstract: Background: Antiretroviral therapy (ART) adherence is the cornerstone of effective HIV management; suboptimal adherence undermines viral suppression, increases transmission risk, and accelerates disease progression. Rwanda reports a 3% adult HIV prevalence, yet determinants of non-adherence at facility level, particularly in western district hospitals, remain insufficiently characterized. This study determined the prevalence and multidimensional determinants of antiretroviral drug (ARD) non-adherence among people living with HIV (PLHIV) at Kirinda District Hospital, Karongi District, Rwanda.

Methods: A cross-sectional analytical mixed-methods study was conducted among 196 adult PLHIV on ART for at least six months at Kirinda District Hospital. Participants were selected through a finite-population-adjusted sample size (Fisher formula). Data were collected via structured questionnaires and five focus group discussions (n=42). Quantitative analysis used IBM SPSS v28; bivariate chi-square and multivariate logistic regression (95% CI; p<0.05) identified independent predictors of non-adherence. Qualitative data were analyzed thematically using NVivo.

Results: The overall non-adherence prevalence was 23.0% (n=45). Among non-adherent participants, 72.4% reported missing doses at least weekly; principal self-reported barriers were HIV-related stigma (16.3%), fear of status disclosure (13.3%), and drug side effects (12.8%). Knowledge gaps were prominent: 27.6% were unaware of ARV effectiveness and 41.3% did not know the risks of non-adherence. Social support was inadequate, with 51.6% uncomfortable discussing HIV status with family. Multivariate analysis identified six independent predictors of non-adherence: widowhood (aOR=2.82, 95% CI: 1.39–12.88, p=0.043), no formal education (aOR=2.61, 95% CI: 2.37–17.24, p=0.002), less than one year on ART (aOR=0.42, 95% CI: 0.05–1.68, p=0.024), experiencing drug side effects (aOR=2.56, 95% CI: 2.30–19.86, p=0.012), lacking knowledge of non-adherence consequences (aOR=2.12, 95% CI: 1.50–8.56, p=0.012), and absence of reminder tools (aOR=1.92, 95% CI: 2.92–20.67, p=0.041). Qualitative findings corroborated these determinants, revealing four major thematic domains: biomedical challenges and side-effect burden, structural and stigma-related barriers, sociocultural dynamics, and treatment literacy gaps.

Conclusion: Non-adherence at Kirinda District Hospital is driven by intersecting biomedical, structural, sociocultural, and knowledge-related determinants. Effective responses require multilevel, patient-centered interventions including enhanced side-effect management, targeted psychosocial support for widowed PLHIV, culturally adapted treatment literacy programmes, universal reminder-tool provision, and strengthened community stigma-reduction initiatives.

Keywords: antiretroviral therapy; ART adherence; non-adherence; PLHIV; HIV; Rwanda; stigma; treatment literacy; mixed methods; district hospital.

Title: Prevalence of non-adherence to antiretroviral therapy among people living with HIV and mitigation used to control in Kirinda District Hospital

Author: Donatien Mbonyintwari, Emile Sebera, Leonisse Uwajeneza, Jerome Mfitumukiza, Larissa Mukire, Jean Damascene Dusabimana, Daniel Ukwishatse, Thierry Patrick Ishimwe, Denyse Umuhoza, Maurice Silari

International Journal of Healthcare Sciences

ISSN 2348-5728 (Online)

Vol. 14, Issue 1, April 2026 - September 2026

Page No: 464-475

Research Publish Journals

Website: www.researchpublish.com

Published Date: 09-July-2026

DOI: https://doi.org/10.5281/zenodo.21295618

Vol. 14, Issue 1, April 2026 - September 2026

Citation
Share : Facebook Twitter Linked In

Citation
Prevalence of non-adherence to antiretroviral therapy among people living with HIV and mitigation used to control in Kirinda District Hospital by Donatien Mbonyintwari, Emile Sebera, Leonisse Uwajeneza, Jerome Mfitumukiza, Larissa Mukire, Jean Damascene Dusabimana, Daniel Ukwishatse, Thierry Patrick Ishimwe, Denyse Umuhoza, Maurice Silari